Utah Medical Products (UTMD)
Utah Medical Products Revenues: 11.21M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
UTMD Revenues Rankings
| Overall | 14th percentile | 3777 of 4432 |
| Sector | 33rd percentile | 311 of 471 in Healthcare |
| Industry | 30th percentile | 47 of 68 in Medical Instruments & Supplies |
UTMD Revenues Range, Past 5 Years
| Minimum | 6.201M | Sep 2010 |
| Maximum | 11.21M | Mar 2012 |
| Average | 7.464M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these UTMD related companies
UTMD News
Utah Medical Products, Inc. (UTMD) Declares $0.24 Quarterly Dividend; 3% Yield
May 08, 10:28AM Street Insider
May 08, 10:28AM Street Insider
Utah Medical Products (UTMD) Reports Q1 Earnings of $0.76; Boosts FY12 EPS Range by 5c
Apr 25, 9:06AM Street Insider
Apr 25, 9:06AM Street Insider
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2012
Apr 25, 9:00AM GlobeNewswire
Apr 25, 9:00AM GlobeNewswire
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DHN
about 58 days ago by MarketBrief
about 58 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3C9K
about 59 days ago by MarketBrief
about 59 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3AqU
about 60 days ago by MarketBrief
about 60 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39IJ
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/383m
about 64 days ago by MarketBrief
about 64 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/36qW
about 65 days ago by MarketBrief
about 65 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/35fy
about 66 days ago by MarketBrief
about 66 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/347o
about 67 days ago by MarketBrief
about 67 days ago by MarketBrief
$UTMD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/32g3
about 70 days ago by MarketBrief
about 70 days ago by MarketBrief
Utah Medical Products, Inc. (UTMD) Declares $0.24 Quarterly Dividend; 3.3% Yield
Feb 07, 10:01AM Street Insider
Feb 07, 10:01AM Street Insider
Utah Medical Products, Inc. Reports Financial Performance for Fourth Quarter and Year 2011
Jan 31, 9:00AM GlobeNewswire
Jan 31, 9:00AM GlobeNewswire
Utah Medical Products, Inc. (UTMD) Raises Quarterly Dividend 2% to $0.24; 3.7% Yield
Nov 01, 10:01AM Street Insider
Nov 01, 10:01AM Street Insider
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2011
Oct 20, 9:00AM GlobeNewswire
Oct 20, 9:00AM GlobeNewswire
We highlighted $UTMD yesterday and it finished up 3.92%, not bad in today's tape.
about 1060 days ago by MOFinancial
about 1060 days ago by MOFinancial
Good dividend, great balance sheet, $UTMD...has been hot lately, don't know if it's safe here...but if you get a pullback, I'm a buyer.
about 1060 days ago by MOFinancial
about 1060 days ago by MOFinancial
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| UTMD | 34.10 | +3.30 | +10.71% | 124.81M |
| UTL | 26.61 | +0.35 | +1.33% | 292.18M |
| UTIW | 15.64 | -0.02 | -0.13% | 1.608B |
| UTI | 12.19 | +0.14 | +1.16% | 301.21M |
| UTHR | 44.24 | -0.48 | -1.07% | 2.373B |
| UNL | 16.31 | +0.09 | +0.55% | |
| UNIS | 4.17 | +0.17 | +4.25% | 308.00M |
| UNH | 55.77 | -0.40 | -0.71% | 58.28B |
| UNG | 16.79 | -0.12 | -0.71% | |
| UNFI | 50.70 | -0.11 | -0.22% | 2.472B |
